V. D. Dodge, E. M. Cox
Dodge & Cox Stock Fund
Dodge & Cox Stock Fund Gilead Sciences Inc stake
total: 130
Dodge & Cox Stock Fund GILD trades
- Total transactions:
- 16
- New positions:
- 1
- Added:
- 6
- Reduced:
- 9
- Held since:
- 2019 Q3
- Held for:
- 27 quarters
- Latest activity:
- 2026 Q1
According to 2026 Q1 report, Dodge & Cox Stock Fund holds 18,093,312 Gilead Sciences Inc (GILD) shares with a market value of roughly $2.52B accounting for 2.20% of the overall portfolio. To date, the estimated cost basis is nearly $65.6 for "buy" trades and estimated average "sell" price is $104.09. Dodge & Cox Stock Fund first purchased GILD in 2019 Q3, initially acquiring about 11.32M shares. Since the initial investment in Gilead Sciences Inc (GILD), Dodge & Cox Stock Fund has made 15 more transactions.
When did Dodge & Cox Stock Fund buy Gilead Sciences Inc (GILD)?
Dodge & Cox Stock Fund first invested in Gilead Sciences Inc (GILD) in 2019 Q3 at the reported quarter-end price of $63.38 per share.
What's the cost basis of Dodge & Cox Stock Fund's GILD stake?
The estimated cost basis for Gilead Sciences Inc (GILD) stake is around $65.60 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $65.60
- Weighted AVG sell price:
- $104.09
Dodge & Cox Stock Fund's historical trades in Gilead Sciences Inc
16 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
2.20%
|
18,093,312
|
$139.37
|
$2,521,664,893
|
-7.24% (-1,411,800)
|
-0.16%
|
|
2025 Q4
|
2.00%
|
19,505,112
|
$122.74
|
$2,394,057,447
|
-13.80% (-3,122,300)
|
-0.32%
|
|
2025 Q3
|
2.09%
|
22,627,412
|
$111.00
|
$2,511,642,732
|
-1.35% (-310,400)
|
-0.03%
|
|
2025 Q2
|
2.17%
|
22,937,812
|
$110.87
|
$2,543,115,216
|
-5.79% (-1,409,000)
|
-0.14%
|
|
2024 Q4
|
2.02%
|
24,346,812
|
$92.37
|
$2,248,915,024
|
-0.10% (-24,300)
|
-0%
|
|
2023 Q3
|
1.98%
|
24,371,112
|
$74.94
|
$1,826,371,133
|
+0.53% (+127,300)
|
+0.01%
|
|
2023 Q2
|
2.01%
|
24,243,812
|
$77.07
|
$1,868,470,591
|
-1.01% (-247,000)
|
-0.02%
|
|
2023 Q1
|
2.29%
|
24,490,812
|
$82.97
|
$2,032,002,672
|
-2.77% (-697,000)
|
-0.07%
|
|
2022 Q3
|
1.97%
|
25,187,812
|
$61.69
|
$1,553,836,122
|
+0.19% (+49,000)
|
+0%
|
|
2021 Q3
|
1.93%
|
25,138,812
|
$69.85
|
$1,755,946,018
|
+29.16% (+5,675,600)
|
+0.43%
|
|
2021 Q2
|
1.50%
|
$68.86
|
+60.81% (+7,360,000)
|
|||
|
2021 Q1
|
0.96%
|
$64.63
|
+10.23% (+1,123,600)
|
|||
|
2020 Q4
|
0.90%
|
$58.26
|
+39.53% (+3,110,800)
|
|||
|
2020 Q2
|
1.01%
|
$76.94
|
-15.78% (-1,474,200)
|
|||
|
2020 Q1
|
1.36%
|
$74.76
|
-17.48% (-1,979,500)
|
|||
|
2019 Q3
|
1.04%
|
$63.38
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.